News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fosun Pharma and Dalian Wanchun Announce Partnership


12/11/2012 1:56:54 PM

by Richard Daverman, PhD

December 11, 2012 -- Shanghai Fosun Pharma and Dalian Wanchun Biotech will establish a JV to develop innovative oncology treatments. Wanchun has in-licensed China rights to plinabulin, a Class 1.1 innovative anti-tumor drug from Nereus Pharma of the US. Through the JV, Fosun will build Wanchun’s development ability and add potential drugs to its pipeline. Wanchun will serve as an innovative drug incubator for Fosun. More details....

Stock Symbols: (SHA: 600196; HK: 2196)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES